(Q33388115)

26 July 2017

title

Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer (English)

1 reference

26 July 2017

1 reference

H Samonigg

1

1 reference

26 July 2017

H Stöger

2

1 reference

26 July 2017

A K Kasparek

3

1 reference

26 July 2017

M Schmid

4

1 reference

26 July 2017

J Dusleag

5

1 reference

26 July 2017

K Pfeiffer

6

1 reference

26 July 2017

M Smola

7

1 reference

26 July 2017

P Steindorfer

8

1 reference

26 July 2017

P Lechner

9

1 reference

26 July 2017

language of work or name

1 reference

1 January 1991

1 reference

Cancer Chemotherapy and Pharmacology

26 July 2017

published in

1 reference

26 July 2017

volume

27

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

477-480

1 reference

Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.

26 July 2017

cites work

1 reference

12 December 2020

Mitoxantrone, 5-fluorouracil and cyclophosphamide in advanced breast cancer

1 reference

12 December 2020

[Randomized trial comparing mitoxantrone with adriamycin in advanced breast cancer]

1 reference

12 December 2020

Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.

1 reference

12 December 2020

A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project

1 reference

12 December 2020

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

1 reference

12 December 2020

Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and pred

1 reference

12 December 2020

Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma

1 reference

12 December 2020

Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy

1 reference

12 December 2020

Mitoxantrone: an active, new antitumor agent with an improved therapeutic index

1 reference

12 December 2020

A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer

1 reference

12 December 2020

Mitoxantrone: mechanism of action, antitumor activity, pharmacokinetics, efficacy in the treatment of solid tumors and lymphomas, and toxicity.

1 reference

12 December 2020

Ftorafur, adriamycin, cyclophosphamide and bcg in the treatment of metastatic breast cancer

1 reference

12 December 2020

High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer

1 reference

12 December 2020

Comparison of induction chemotherapies for metastatic breast cancer. An Eastern Cooperative Oncology Group Trial

1 reference

12 December 2020

Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer

1 reference

12 December 2020

A randomized trial of doxorubicin, mitoxantrone and bisantrene in advanced breast cancer (a South West Oncology Group Study).

1 reference

12 December 2020

Pharmacology of mitoxantrone in cancer patients

1 reference

12 December 2020

Prednimustine in advanced breast cancer: a review

1 reference

12 December 2020

Mitoxantrone: an active new agent in the treatment of advanced breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00685163

1 reference

Dimensions Publication ID

26 July 2017

1020128891

0 references

Fatcat ID

release_4ase5wrbafcs7hi3a5a627h75y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4ase5wrbafcs7hi3a5a627h75y

24 November 2022

mapped directly with Wikidata item

1 reference